case_images: PMC5693911_01
case_images: PMC5693911_02
case_images: PMC5693911_03
case_images: Picture of our patient at the age of 27 years.
case_images: fendo-08-00309-g001.jpg
case_images: PMC5693911_03_fendo-08-00309-g001.jpg
case_images: F1
case_images: However, during examination she displayed an infantile appearance (149 cm, 43 kg), pale skin, puffy face, no axillary or pubic hair (Tanner AH1 and PH1, respectively), no breast development (Tanner B1-2), and with no history of a menstrual cycle (Figure 1).
case_images: PMC5693911_04
case_images: Magnetic resonance imaging of smaller pituitary gland.
case_images: fendo-08-00309-g002.jpg
case_images: PMC5693911_04_fendo-08-00309-g002.jpg
case_images: F2
case_images: MRI revealed a smaller but otherwise normal pituitary gland (Figure 2).
case_images: PMC5693911_05
case_images: PMC5693911_06
case_images: PMC5693911_07
case_images: Ultrasonography of uterus at the initiation of the treatment.
case_images: fendo-08-00309-g003.jpg
case_images: PMC5693911_07_fendo-08-00309-g003.jpg
case_images: F3
case_images: The titration of hormonal substitution therapy and findings from hormonal cytology and sonography of the uterus are presented in Table 2 and Figure 3.
case_images: PMC5693911_08